Kala制药（KALA.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他96.38%
机构投资者3.61%
个人与内部人士<0.01%

主要股东

主要股东最新
股东
Vanguard Capital Management, LLC	1.67%	32.20 万	1.66%	+32.02 万	2026/06/30
Geode Capital Management, LLC	0.75%	14.52 万	0.72%	+13.99 万	2026/06/30
BlackRock, Inc.	0.37%	7.15 万	0.37%	+7.13 万	2026/06/30
LifeSci Capital, LLC	0.23%	4.40 万	<0.01%	+0	2025/12/30
Northern Trust Global Investments	0.22%	4.16 万	0.21%	+4.14 万	2026/06/30
Oxford Finance LLC	0.17%	3.24 万	<0.01%	+0	2025/11/25
Qube Research & Technologies Ltd	0.06%	1.11 万	--	+1.11 万	2026/06/30
The Goldman Sachs Group, Inc.	0.06%	1.09 万	0.05%	+1.06 万	2026/06/30
UBS Asset Management AG	0.05%	9,057.00	0.04%	+7,720.00	2026/06/30
SR One Capital Management, LP	0.04%	6,884.00	<0.01%	+0	2025/10/14
Baker Bros. Advisors LP	0.01%	2,312.00	<0.01%	+0	2026/03/31
Spearhead Insurance Solutions Idf, Llc	<0.01%	775.00	<0.01%	+0	2025/02/14
Tower Research Capital Europe Limited	<0.01%	616.00	<0.01%	+616.00	2026/06/30
Barclays Bank Plc	<0.01%	608.00	--	+608.00	2026/06/30
Andrew KovenFormer Lead Independent Director	<0.01%	270.00	<0.01%	+0	2025/12/29
Darius KharabiFormer Chief Business Officer	<0.01%	258.00	<0.01%	+0	2025/10/22
Charles MyersFormer Independent Director	<0.01%	178.00	<0.01%	+0	2025/12/29
Marjan FaridFormer Independent Director	<0.01%	177.00	<0.01%	+0	2025/12/29
Gregory PerryFormer Independent Director	<0.01%	140.00	<0.01%	+0	2025/06/15
Morgan Stanley	<0.01%	28.00	<0.01%	-30.00	2026/06/30